注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
ARS Pharmaceuticals Inc(原名:Silverback Therapeutics Inc)是一家生物制药公司。该公司正在开发neffy(以前称为ARS-1),这是一种用于临床开发的鼻内肾上腺素产品,用于患有1型过敏反应的患者及其护理人员,包括可能导致过敏反应的食物、药物和昆虫叮咬。该公司设计和开发了一种在小型鼻喷雾装置中提供肾上腺素注射样吸收的neffy。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Pratik Shah | 54 | - | Chairman of the Board |
Thomas B. Casale | - | - | Member of Scientific Advisory Board |
Brenton L. Saunders | 54 | 2021 | Director |
Michael Kaliner | - | - | Member of Scientific Advisory Board |
Jonathan M. Spergel | - | 2023 | Member of the Scientific Advisory Board |
David I. Bernstein | - | 2023 | Member of Scientific Advisory Board |
David M. Fleischer | - | 2023 | Member of Scientific Advisory Board |
Richard F. Lockey | - | - | Member of Scientific Advisory Board |
Carlos A. Camarago | - | 2023 | Member of Scientific Advisory Board |
Laura K. Shawver | 66 | 2022 | Director |
Motohiro Ebisawa | - | - | Member of Scientific Advisory Board |
Richard Lowenthal | 58 | 2022 | Founder, President, CEO & Director |
John Oppenheimer | - | 2023 | Member of Scientific Advisory Board |
Phillip M. Schneider | 68 | - | Independent Director |
Rajeev Dadoo | 53 | 2021 | Independent Director |
Peter Kolchinsky | 47 | 2021 | Independent Director |
Peter A. Thompson | 64 | 2022 | Independent Director |
Phillip Lieberman | - | - | Member of Scientific Advisory Board |
Saqib Islam | 54 | 2022 | Independent Director |
Michael Kelly | 58 | - | Independent Director |
Anne K. Ellis | - | 2021 | Member of Scientific Advisory Board |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核